TardiMed Sciences

Holding Companies & Conglomerates · New Jersey, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

50 Tice Blvd Ste A26, Woodcliff Lake, Ne...

Phone Number

(201) 645-4761

Revenue

<$5 Million

Industry

Holding Companies & Conglomerates Business Services Project Management
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
4
1
5
3
3

About TardiMed Sciences

Zach is a biopharmaceutical inventor, entrepreneur and executive. He is a Partner at TardiMed where he has Co-Founded several life science companies that span multiple therapeutic areas and stages of development. He also serves in an operating role for several of the TardiMed portfolio companies and is currently the President and a member of the Board of Directors for Timber Pharmaceuticals. Previously, Zach was the Co-Founder and President at Patagonia Pharmaceuticals, a privately-owned specialty pharmaceutical company developing treatments for rare dermatologic diseases. He was the lead inventor on all of Patagonias technologies and oversaw their development from concept through Phase 2 studies. In 2018, Patagonia was awarded a $1.5 million grant from the FDA for which Zach served as the Principal Investigator. Zach has a BS in Marine Science and Biology from the University of Miami and an MST in Adolescent Science Biology from Pace University. Michael is a successful biopharmaceuticRead more
TardiMed Sciences's Social MediaPopular SearchesTardimed Sciences LLCTardiMed SciencesSIC Code 67,671NAICS Code 55,551Show more

TardiMed Sciences Org Chart

PhoneEmail
MD
United States flag for contact location.

Managing Partner

PhoneEmail
AI
United States flag for contact location.

Healthcare Assistant

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is TardiMed Sciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to TardiMed Sciences

Compare insights from companies similar to TardiMed Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

TardiMed Sciences

<$5M
11-50
Private
-
2011
MD
Michael DerbyManaging Partner
<$5M
11-50
Private
$39.7M
2015
TC
Traci CarmanFounder & Chief Financial Officer, Amp & Director, Amp
<$5M
11-50
Private
-
2012
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
$10.6M
-
Peter Vanderklish, Chief Science Officer at Spinogenix
Peter VanderklishChief Science Officer
<$5M
1-10
Private
-
2018
MP
Mahlaqa PatelQuality Assurance Vice President, Regulatory Affairs
<$5M
11-50
Private
-
2008
CO
Christopher OlisAssociate Director, Accounting
Illustration of an envelope

Company Profile Activity

i

Among all Holding Companies & Conglomerates companies

Low Activity

High Activity

Activity Insights

TardiMed Sciences is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.

What does this means?

TardiMed Sciences is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about TardiMed Sciences.

TardiMed Sciences Tech Stack

A closer look at the technologies used by TardiMed Sciences

Top Holding Companies & Conglomerates Companies

Frequently Asked Questions Regarding TardiMed Sciences

What is TardiMed Sciences's official website?
TardiMed Sciences's official website is www.tardimed.com
What is TardiMed Sciences's Revenue?
TardiMed Sciences's revenue is <$5 Million
What is TardiMed Sciences's SIC code?
TardiMed Sciences's SIC: 67,671
What is TardiMed Sciences's NAICS code?
TardiMed Sciences's NAICS: 55,551
How many employees does TardiMed Sciences have?
TardiMed Sciences has 11-50 employees
What industry does TardiMed Sciences belong to?
TardiMed Sciences is in the industry of: Holding Companies & Conglomerates, Business Services, Project Management
What is TardiMed Sciences competition?
TardiMed Sciences top competitors include: Epirium, Receptor Life Sciences, Evergreen Pharma Service, Chaz Hinzman
What technology does TardiMed Sciences use?
Some of the popular technologies that TardiMed Sciences uses are: HostPapa, Microsoft 365, Microsoft Exchange Online
How do I contact TardiMed Sciences?
TardiMed Sciences contact info: Phone number: (201) 645-4761 Website: www.tardimed.com
What does TardiMed Sciences do?

Zach is a biopharmaceutical inventor, entrepreneur and executive. He is a Partner at TardiMed where he has Co-Founded several life science companies that span multiple therapeutic areas and stages of development. He also serves in an operating role for several of the TardiMed portfolio companies and is currently the President and a member of the Bo... ard of Directors for Timber Pharmaceuticals. Previously, Zach was the Co-Founder and President at Patagonia Pharmaceuticals, a privately-owned specialty pharmaceutical company developing treatments for rare dermatologic diseases. He was the lead inventor on all of Patagonias technologies and oversaw their development from concept through Phase 2 studies. In 2018, Patagonia was awarded a $1.5 million grant from the FDA for which Zach served as the Principal Investigator. Zach has a BS in Marine Science and Biology from the University of Miami and an MST in Adolescent Science Biology from Pace University. Michael is a successful biopharmaceutical entrepreneur, operating executive and investor. He has founded or co-founded multiple biopharmaceutical companies and has a passion for developing and commercializing innovative products that make a major impact on the lives of patients globally. Michael is the Founder and Managing Partner of TardiMed Sciences, which is building a portfolio of innovative companies that address some of medicines most pressing diseases. In 2015, Michael co-founded Castle Creek Pharmaceuticals which, under his leadership, raised more than $120 million and was built into a late clinical-stage company developing important therapies for patients with rare dermatologic conditions. Prior to Castle Creek, Michael founded Norphan Pharmaceuticals, which developed drugs for patients with rare neurologic diseases, including one of the first drugs to gain U.S. FDA approval for the treatment of Duchenne muscular dystrophy. Earlier in his career, Michael was a venture capitalist and operating executive, holding key commercial roles at Merck & Co. and Forest ...Read More

What are TardiMed Sciences social media links?
TardiMed Sciences Linkedin page
Is TardiMed Sciences a public company?
TardiMed Sciences is private company therefore does not currently have an official ticker symbol
See more information about TardiMed Sciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.